Filing Details

Accession Number:
0000914190-16-000741
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-17 18:03:11
Reporting Period:
2016-08-15
Filing Date:
2016-08-17
Accepted Time:
2016-08-17 18:03:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI Pharmaceutical Preparations (2834) 522286452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296549 Arie Belldegrun C/o Arno Therapeutics, Inc.
200 Route 31 North, Suite 104
Flemington NJ 08822
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-15 714,285 $0.00 2,262,838 No 4 P Indirect Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2016 Series F Warrants (right to buy) Acquisiton 2016-08-15 357,142 $0.00 357,142 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
357,142 2016-08-15 2021-08-15 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,115 Direct
Common Stock 858,094 Indirect Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust
Common Stock 254,887 Indirect Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust
Common Stock 379,294 Indirect Belldegrun Family Trust
Common Stock 174,644 Indirect MDRB Partnership, L.P.
Footnotes
  1. The reported securities are included within 714,285 Issuer units purchased by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
  2. The Reporting Person is the trustee of the profit sharing plan that owns the securities.
  3. Although the Reporting Person is not a trustee of the BTL Trust, the Reporting Person is a beneficiary of the BTL Trust, and as such may be deemed to be the beneficial owner of the securities owned by the BTL Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  4. Although the Reporting Person is not a trustee of the Tampere Trust, the Reporting Person is a beneficiary of the Tampere Trust, and as such may be deemed to be the beneficial owner of the securities owned by the Tampere Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  5. The Reporting Person is the trustee of the family trust that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  6. The Reporting Person is the managing partner of the limited partnership that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.